Haemonetics (HAE) Tops Q3 EPS by 15c, Revenues Beat
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $87.66 --0%
Revenue Growth %: +8.4%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
WF, CWBC, GLTO, More
Revenue Growth %: +8.4%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
WF, CWBC, GLTO, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.81, $0.15 better than the analyst estimate of $0.66. Revenue for the quarter came in at $240 million versus the consensus estimate of $225.73 million.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Snap shares surge 26% on earnings beat, optimistic outlook
- Nomura Holdings (NMR) Reports In-Line Q1 EPS
Create E-mail Alert Related Categories
Corporate News, EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
